Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Furthermore, in January 2025, the FDA approved semaglutide (Ozempic ) for reducing the risk of kidney failure and disease progression in patients with diabetes and chronic kidney disease (CKD), making it the first GLP-1 agent indicated for the treatment of CKD (Perkovic et al., 2024)
As a result, Novo Nordisk and Eli Lillys historical dominance will face its first real structural challenge, not from USA or European biotech startups, but from Indian and Chinese players scaling biosimilars and new molecular entities for export
This reality is often overlooked in society, and it has been a personal mission of mine to advocate for those who face these challenges
& Cohn, Z
US$ 24.40
US$ 22.43
US$ 28.17
US$ 28.98
US$ 20.34
US$ 28.79
